New Tool: PMMI ProSource
Check out our packaging and processing solutions finder, PMMI ProSource.

Novartis to Forgo COVID-19 Profits in Developing Countries

The company’s generic division will offer 15 medicines at zero profit.

When a global pandemic strikes, it’s important to use the resources at your disposal to help others. According to a recent FiercePharma article, Swiss-based pharma giant Novartis is doing its part by promising zero profit from sales of 15 generic and over-the-counter drugs that manage COVID-19 symptoms in developing countries. The medicines, all from Novartis’ Sandoz unit, include widely used antibiotics and anti-inflammatory therapies and medications for cardiovascular and gastrointestinal diseases. On top of that, Novartis has pledged to donate $40 million to support communities affected by the pandemic.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub